Literature DB >> 30191007

Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.

Elizabeth M Brunt1,1, Valerie Paradis2,2, Christine Sempoux3,3, Neil D Theise4,4.   

Abstract

Recent WHO classification for combined hepatocellular-cholangiocarcinoma and recognized stem cell subtypes has increased attention to such tumors; however, the resulting burst of reporting and research indicates that this classification, while provocative, is incomplete for description of the full array of primary liver carcinomas with biphenotypic (hepatobiliary) differentiation. We review the history of such lesions and consider the wider array of such tumors previously described. Mixed hepatobiliary phenotypes and immunophenotypes are found in individual tumors at the tissue level - with architectural and cytologic features supportive of both differentiation states - and at the cellular level, with individual cells that display cytology of one cell type, but immunophenotypically showing mixed expression. Pathobiologic and clinical questions to be answered by future research are suggested.

Entities:  

Keywords:  cholangiocarcinoma; cholangiolocellular carcinoma; combined hepatocellular–cholangiocarcinoma; hepatocarcinogenesis; hepatocellular carcinoma; liver progenitor cell; liver stem cell; mixed hepatobiliary carcinoma; primary liver carcinoma; stem cell tumor; stemness

Year:  2015        PMID: 30191007      PMCID: PMC6095308          DOI: 10.2217/hep.15.8

Source DB:  PubMed          Journal:  Hepat Oncol        ISSN: 2045-0923


  58 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Expression of keratin 19 is related to high recurrence of hepatocellular carcinoma after radiofrequency ablation.

Authors:  Kaoru Tsuchiya; Mina Komuta; Yutaka Yasui; Nobuharu Tamaki; Takanori Hosokawa; Ken Ueda; Teiji Kuzuya; Jun Itakura; Hiroyuki Nakanishi; Yuka Takahashi; Masayuki Kurosaki; Yasuhiro Asahina; Nobuyuki Enomoto; Michiie Sakamoto; Namiki Izumi
Journal:  Oncology       Date:  2011-07-07       Impact factor: 2.935

Review 3.  Combined hepatocellular cholangiocarcinoma: a case report and review of literature.

Authors:  Shailender Singh; Subhankar Chakraborty; Neelima Bonthu; Stanley Radio; Shahid M Hussain; Aaron Sasson
Journal:  Dig Dis Sci       Date:  2013-02-09       Impact factor: 3.199

4.  A clinicopathological study on combined hepatocellular and cholangiocarcinoma.

Authors:  J Taguchi; O Nakashima; M Tanaka; T Hisaka; T Takazawa; M Kojiro
Journal:  J Gastroenterol Hepatol       Date:  1996-08       Impact factor: 4.029

5.  Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma.

Authors:  Makoto Shibuya; Fukuo Kondo; Keiji Sano; Tadahiro Takada; Takehide Asano
Journal:  J Hepatobiliary Pancreat Sci       Date:  2011-07       Impact factor: 7.027

6.  Histopathological classification of hepatocellular carcinoma.

Authors:  Massimo Roncalli; Young Nyun Park; Luca Di Tommaso
Journal:  Dig Liver Dis       Date:  2010-07       Impact factor: 4.088

7.  Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications.

Authors:  P C Wu; J W Fang; V K Lau; C L Lai; C K Lo; J Y Lau
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

8.  Combined hepatocellular-cholangiocarcinomas exhibit progenitor features and activation of Wnt and TGFβ signaling pathways.

Authors:  Cédric Coulouarn; Catherine Cavard; Laura Rubbia-Brandt; Anne Audebourg; Florent Dumont; Sébastien Jacques; Pierre-Alexandre Just; Bruno Clément; Hélène Gilgenkrantz; Christine Perret; Benoît Terris
Journal:  Carcinogenesis       Date:  2012-06-13       Impact factor: 4.944

9.  Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings.

Authors:  K Aoki; K Takayasu; T Kawano; Y Muramatsu; N Moriyama; F Wakao; J Yamamoto; K Shimada; T Takayama; T Kosuge
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

10.  Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma.

Authors:  Gregor Krings; Rageshree Ramachandran; Dhanpat Jain; Tsung-Teh Wu; Matthew M Yeh; Michael Torbenson; Sanjay Kakar
Journal:  Mod Pathol       Date:  2013-01-25       Impact factor: 7.842

View more
  10 in total

1.  cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation.

Authors:  Elizabeth Brunt; Shinichi Aishima; Pierre-Alain Clavien; Kathryn Fowler; Zachary Goodman; Gregory Gores; Annette Gouw; Alex Kagen; David Klimstra; Mina Komuta; Fukuo Kondo; Rebecca Miksad; Masayuki Nakano; Yasuni Nakanuma; Irene Ng; Valerie Paradis; Young Nyun Park; Alberto Quaglia; Massimo Roncalli; Tania Roskams; Michiie Sakamoto; Romil Saxena; Christine Sempoux; Claude Sirlin; Ashley Stueck; Swan Thung; W M S Tsui; Xin-Wei Wang; Aileen Wee; Hirohisa Yano; Matthew Yeh; Yoh Zen; Jessica Zucman-Rossi; Neil Theise
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

2.  Look into hepatic progenitor cell associated trait: Histological heterogeneity of hepatitis B-related combined hepatocellular-cholangiocarcinoma.

Authors:  Xiong Cai; Jun Xiong; Qing-Gang Hu; Qiu-Dong Zhao; Dong Wu; Li-Gong Tang; Chi-Dan Wan; Li-Xin Wei
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-12-21

3.  Decreased ARG1 expression as an adverse prognostic phenotype in non-alcoholic non-virus-related hepatocellular carcinoma.

Authors:  Yasuyuki Shigematsu; Gulanbar Amori; Hiroaki Kanda; Yu Takahashi; Yutaka Takazawa; Kengo Takeuchi; Kentaro Inamura
Journal:  Virchows Arch       Date:  2022-04-23       Impact factor: 4.535

4.  Assessment of primary liver carcinomas other than hepatocellular carcinoma (HCC) with LI-RADS v2018: comparison of the LI-RADS target population to patients without LI-RADS-defined HCC risk factors.

Authors:  Tyler J Fraum; Roberto Cannella; Daniel R Ludwig; Richard Tsai; Muhammad Naeem; Maverick LeBlanc; Amber Salter; Allan Tsung; Anup S Shetty; Amir A Borhani; Alessandro Furlan; Kathryn J Fowler
Journal:  Eur Radiol       Date:  2019-10-25       Impact factor: 5.315

Review 5.  From diagnosis to treatment of hepatocellular carcinoma: An epidemic problem for both developed and developing world.

Authors:  Dimitrios Dimitroulis; Christos Damaskos; Serena Valsami; Spyridon Davakis; Nikolaos Garmpis; Eleftherios Spartalis; Antonios Athanasiou; Demetrios Moris; Stratigoula Sakellariou; Stylianos Kykalos; Gerasimos Tsourouflis; Anna Garmpi; Ioanna Delladetsima; Konstantinos Kontzoglou; Gregory Kouraklis
Journal:  World J Gastroenterol       Date:  2017-08-07       Impact factor: 5.742

Review 6.  Combined Hepatocellular-Cholangiocarcinoma: Changes in the 2019 World Health Organization Histological Classification System and Potential Impact on Imaging-Based Diagnosis.

Authors:  Tae Hyung Kim; Haeryoung Kim; Ijin Joo; Jeong Min Lee
Journal:  Korean J Radiol       Date:  2020-07-27       Impact factor: 3.500

Review 7.  Hepatocellular carcinoma: a review of diagnostic challenges for the pathologist.

Authors:  Alberto Quaglia
Journal:  J Hepatocell Carcinoma       Date:  2018-11-08

Review 8.  Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.

Authors:  Joon Hyuk Choi; Jae Y Ro
Journal:  Biomedicines       Date:  2022-07-29

9.  Human primary liver cancer-derived organoid cultures for disease modeling and drug screening.

Authors:  Laura Broutier; Gianmarco Mastrogiovanni; Monique Ma Verstegen; Hayley E Francies; Lena Morrill Gavarró; Charles R Bradshaw; George E Allen; Robert Arnes-Benito; Olga Sidorova; Marcia P Gaspersz; Nikitas Georgakopoulos; Bon-Kyoung Koo; Sabine Dietmann; Susan E Davies; Raaj K Praseedom; Ruby Lieshout; Jan N M IJzermans; Stephen J Wigmore; Kourosh Saeb-Parsy; Mathew J Garnett; Luc Jw van der Laan; Meritxell Huch
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

10.  Murine hepatoblast-derived liver tumors resembling human combined hepatocellular-cholangiocarcinoma with stem cell features.

Authors:  Xiong Cai; Heli Li; David E Kaplan
Journal:  Cell Biosci       Date:  2020-03-13       Impact factor: 7.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.